Temasek’s 65 Equity Makes Europe Foray With Swiss Pharma Merger

» Temasek’s 65 Equity Makes Europe Foray With Swiss Pharma Merger




Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s acquisition of Cerbios-Pharma SA, marking its first deal in Europe.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *